Burzynski Research Institute Signs Research Agreement with the University of Alabama at Birmingham, Division of Preventive Medicine, Biostatistics and Bioinformatics Shared Facility
9/29/2009 10:07:34 AM
More...
|
Burzynski Research Institute: Metastatic Colon Cancer: In a Randomized Phase II Clinical Study, Antineoplaston Therapy Doubled the 5-Year Survival Rate Following Curative Resection of Hepatic Metastases
5/27/2009 8:20:34 AM
More...
|
Burzynski Research Institute Presents Positive Results From Phase II Trials of ANP for Inoperable Brainstem Glioma at the Congress
5/11/2009 12:00:54 PM
More...
|
Burzynski Research Institute Announces Positive Results of Phase II ANP Clinical Trial
5/6/2009 8:41:24 AM
More...
|
Burzynski Research Institute Partners with Premier Research to Manage Phase III Clinical Study of Children with Newly-Diagnosed Diffuse Intrinsic Brainstem Glioma
1/26/2009 10:05:32 AM
More...
|
U.S. FDA Grants Orphan Drug Designation for Burzynski Research Institute’s Antineoplaston Treatment for Gliomas
12/2/2008 10:51:20 AM
More...
|
Burzynski Research Institute Presents Promising Phase II Data on Malignant Glioma
11/21/2008 8:45:48 AM
More...
|
Thought Leaders from Burzynski Research Institute Present Encouraging Data on Antineoplastons for Treatment of Malignant Gliomas
11/20/2008 9:42:41 AM
More...
|
Brain Tumor Survivors Visit Burzynski Research Institute, Manufacturer Of Life Saving Medication
10/19/2005 5:11:48 PM
More...
|
Burzynski Research Institute Receives Orphan Drug Designation For Antineoplastons A10 And AS2-1 For Treatment Of Brain Stem Glioma
10/19/2005 5:10:19 PM
More...
|